Anti-Benzoylecgonine (BNG-9735)
Anti-Benzoylecgonine (BNG-9735)
Product No.: B146
- -
- -
Clone BNG-9735 Target Benzoylecgonine Formats AvailableView All Product Type Hybridoma Monoclonal Antibody Isotype Mouse IgG1 κ Applications ELISA , Lateral Flow |
- -
- -
Antibody DetailsProduct DetailsProduct Concentration ≥1.0 mg/ml Purity >98% by SDS Page Formulation Formulated in phosphate buffered saline, pH 7.2 and contains 0.05% sodium azide. State of Matter Liquid Product Preparation This monoclonal antibody is purified by Protein A chromatography. Storage and Handling 2-8ºC Regulatory Status Research Use Only Country of Origin USA Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change. DescriptionSpecificity Anti-benzoylecgonine (Clone BNG-9735) is specific for benzoylecgonine. Background Benzoylecgonine is a major metabolite of cocaine, a powerful stimulant drug derived from the coca plant. When cocaine is ingested, it is metabolized in the liver into various compounds, with benzoylecgonine being the primary metabolite that can be detected in urine. Unlike cocaine, benzoylecgonine has a longer half-life and can persist in the body for an extended period, making it a reliable marker for recent cocaine use. Consequently, drug tests often target benzoylecgonine to identify individuals who have used cocaine within a specific timeframe. This metabolite is frequently screened in workplace drug testing, forensic analyses, and legal situations to ascertain recent cocaine consumption, contributing to efforts aimed at detecting and addressing substance abuse. Antigen DetailsResearch Area Drug of Abuse . Matched Pair . IVD Raw Material References & Citations1. Nickley J, Pesce AJ, Krock K. Drug Test Anal. 9(8):1214-1216. (2017). Technical Protocols |
Formats Available
